ABBOTT LABORATORIES — Director's Dealing 2015

Apr 2, 2015

Page 1 of 1

SEC FORM 4

SEC Form 4 FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Check this box if no longer subject to Section 16. Form 4 or Form 5 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP obligations may continue. See Instruction 1(b).

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person*Foltz CharlesD(Last)(First)(Middle)100 ABBOTT PARK ROAD(Street)ABBOTTPARKIL60064(City)(State)(Zip)	1. Name and Address of Reporting Person*Foltz CharlesD(Last)(First)(Middle)100 ABBOTT PARK ROAD(Street)ABBOTTPARKIL60064(City)(State)(Zip)	1. Name and Address of Reporting Person*Foltz CharlesD(Last)(First)(Middle)100 ABBOTT PARK ROAD(Street)ABBOTTPARKIL60064(City)(State)(Zip)	1. Name and Address of Reporting Person*Foltz CharlesD(Last)(First)(Middle)100 ABBOTT PARK ROAD(Street)ABBOTTPARKIL60064(City)(State)(Zip)	2. Issuer NameandTicker or Trading SymbolABBOTT LABORATORIES [ABT]	2. Issuer NameandTicker or Trading SymbolABBOTT LABORATORIES [ABT]	2. Issuer NameandTicker or Trading SymbolABBOTT LABORATORIES [ABT]	2. Issuer NameandTicker or Trading SymbolABBOTT LABORATORIES [ABT]	2. Issuer NameandTicker or Trading SymbolABBOTT LABORATORIES [ABT]	2. Issuer NameandTicker or Trading SymbolABBOTT LABORATORIES [ABT]	2. Issuer NameandTicker or Trading SymbolABBOTT LABORATORIES [ABT]	2. Issuer NameandTicker or Trading SymbolABBOTT LABORATORIES [ABT]	2. Issuer NameandTicker or Trading SymbolABBOTT LABORATORIES [ABT]	2. Issuer NameandTicker or Trading SymbolABBOTT LABORATORIES [ABT]	2. Issuer NameandTicker or Trading SymbolABBOTT LABORATORIES [ABT]	2. Issuer NameandTicker or Trading SymbolABBOTT LABORATORIES [ABT]	5. Relationship of Reporting Person(s) to Issuer(Check all applicable)Director10% OwnerXOfficer (give titlebelow)Other (specifybelow)Senior Vice President	5. Relationship of Reporting Person(s) to Issuer(Check all applicable)Director10% OwnerXOfficer (give titlebelow)Other (specifybelow)Senior Vice President	5. Relationship of Reporting Person(s) to Issuer(Check all applicable)Director10% OwnerXOfficer (give titlebelow)Other (specifybelow)Senior Vice President	5. Relationship of Reporting Person(s) to Issuer(Check all applicable)Director10% OwnerXOfficer (give titlebelow)Other (specifybelow)Senior Vice President	5. Relationship of Reporting Person(s) to Issuer(Check all applicable)Director10% OwnerXOfficer (give titlebelow)Other (specifybelow)Senior Vice President	5. Relationship of Reporting Person(s) to Issuer(Check all applicable)Director10% OwnerXOfficer (give titlebelow)Other (specifybelow)Senior Vice President	5. Relationship of Reporting Person(s) to Issuer(Check all applicable)Director10% OwnerXOfficer (give titlebelow)Other (specifybelow)Senior Vice President
				3. Date of Earliest Transaction (Month/Day/Year)04/01/2015
				4. If Amendment, Date of Original Filed (Month/Day/Year)												6. Individual or Joint/Group Filing (CheckApplicable Line)XForm filed by One Reporting PersonForm filed by More than One ReportingPerson
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)				2. TransactionDate(Month/Day/Year)			2A. DeemedExecution Date,if any(Month/Day/Year)			3.TransactionCode (Instr.8)			4. Securities Acquired(A) or Disposed Of (D)(Instr. 3, 4 and 5)					5. AmountofSecuritiesBeneficiallyOwnedFollowingReportedTransaction(s) (Instr. 3and 4)		6.OwnershipForm:Direct (D)or Indirect(I) (Instr. 4)		7. Natureof IndirectBeneficialOwnership(Instr. 4)
										Code		V	Amount		(A)or(D)		Price
Common shares without par value				04/01/2015						F			2,677		D		$ 46.33	93,333		D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned(e.g., puts, calls, warrants, options, convertible securities)
1. Title ofDerivativeSecurity(Instr. 3)	2.Conversionor ExercisePrice ofDerivativeSecurity	3. TransactionDate(Month/Day/Year)	3A. DeemedExecution Date,if any(Month/Day/Year)	4.TransactionCode (Instr.8)		5.NumberofDerivativeSecuritiesAcquired(A) orDisposedof (D)(Instr. 3, 4and 5)			6. Date Exercisable andExpiration Date(Month/Day/Year)				7. Title andAmount ofSecuritiesUnderlyingDerivativeSecurity(Instr. 3 and 4)				8. Price ofDerivativeSecurity(Instr. 5)		9. NumberofderivativeSecuritiesBeneficiallyOwnedFollowingReportedTransaction(s) (Instr. 4)		10.OwnershipForm:Direct (D)or Indirect(I) (Instr. 4)	11. Natureof IndirectBeneficialOwnership(Instr. 4)
				Code	V	(A)		(D)	DateExercisable		ExpirationDate		Title	AmountorNumberofShares

Explanation of Responses:

John A. Berry, by Power of Attorney for Charles D. 04/02/2015 Foltz

** Signature of Reporting Person Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

• If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

• ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

4/2/2015